Bluewater Bio, a fast growing UK-based water company, has attracted interest from several potential buyers as its current owner, Salica, considers a sale. Rothschild & Co’s UK mid-market team and BDA have been appointed as advisors to assist in the potential transaction.
Over the past three years, Bluewater Bio has achieved an impressive annual compound growth rate of 38%, with its FilterClear technology growing by 83% over the same period. In the first quarter of this year alone, the company secured 86% of its £40 million full-year revenue forecast. With a strong export business focused largely outside the United States, Bluewater Bio is well protected against the impact of rising tariffs, enhancing its resilience in today's market.
The company’s core technologies, HYBACS and FilterClear, are well-established in the water and wastewater treatment sectors, offering market-leading performance. FilterClear, in particular, is playing a critical role in phosphorus removal as part of the UK’s long-term infrastructure improvements extending to at least 2035. Internationally, the technology is increasingly being adopted in desalination pretreatment projects.
Over the past three years, Bluewater Bio has achieved an impressive annual compound growth rate of 38%, with its FilterClear technology growing by 83% over the same period
Richard Haddon, CEO and Executive Chair of Bluewater Bio, said: “We have grown and developed beyond expectations and have incredible traction both in the UK and overseas, which has attracted investor interest. We have plans to further accelerate growth and this could be the time to bring in fresh investment to underpin the next stage in our strategy. With the global realisation of the importance of environmentally friendly water treatment, our technology is highly sought after, and for us to match demand and continue to match the needs of our clients, this is an optimum moment to consider further investment. Our technologies reduce capital and operating costs, operating plant size, environmental damage and construction times. We are excited about the long-term strategic opportunity to help water companies become more efficient in how they invest and operate.”
Demand for Bluewater Bio’s FilterClear and HYBACS technologies remains strong both domestically, as UK water companies strive to meet tough environmental and service obligations, and internationally, particularly across the Middle East, where the need for scalable water and wastewater solutions continues to grow. The company recently signed an agreement with a major Middle Eastern water operator, opening new avenues for international expansion.
Founded in 2009, Bluewater Bio is headquartered in Marylebone, London, with additional offices in the Middle East. The current management team is marking their tenth year at the helm.
